COGNITION THERAPEUTICS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cognition Therapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2024.
  • Cognition Therapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.15M, a 11.9% increase year-over-year.
  • Cognition Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2023 was $4.35M, a 21.9% increase from 2022.
  • Cognition Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2022 was $3.57M, a 31.1% decline from 2021.
  • Cognition Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2021 was $5.18M, a 991% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.15M +$122K +11.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q4 2023 $4.35M $1.07M +$169K +18.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $4.19M $1.07M +$294K +37.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $3.89M $1.03M +$133K +14.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $3.76M $1.19M +$186K +18.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $3.57M $902K -$4.02M -81.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $7.59M $777K +$705K +979% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $6.88M $892K +$798K +849% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $6.09M $1M +$903K +921% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $5.18M $4.92M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $72K -$57K -44.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $94K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $98K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $129K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.